Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sophion Bioscience logo — Empowering drug discovery with superior, efficient automated...

Sophion Bioscience

Empowering drug discovery with superior, efficient automated patch clamping technology.

Founded 2000 51-200 employees Biotechnology

General Information

Company Name Sophion Bioscience
Founded Year 2000
Founders / Decision Makers
Team member
Employees 51-200
Industries Biotechnology
Social

Get notified when Sophion Bioscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sophion Bioscience

Sophion Bioscience is a pioneering force in the field of biotechnology, specializing in automated patch clamping technology. Their flagship products, QPatch 16 and QPatch HT (48-channels), are designed to provide high-quality patch clamp data on an industrial scale across all ion channel types. What sets Sophion apart is its emphasis on delivering innovative products and integrated solutions, with features such as built-in cell preparation and QPlate exchange facilities, allowing for several hours of unattended operation. The unique microfluidic flow channel system in the QPlates enables rapid liquid exchange around each cell, offering the capacity to test multiple compounds or varying concentrations on the same cell. Founded in 2000, Sophion Bioscience is empowering drug discovery by helping companies develop superior drugs more efficiently.

Taxonomy: Automated Patch Clamping, Ion Channels, Drug Discovery, Sophion Bioscience, QPatch 16, QPatch HT, High-Quality Data, Microfluidic Flow Channel System, Cell Preparation, QPlate Exchange, Integrated Solutions, Industrial Scale, Unattended Operation, Rapid Liquid Exchange, Drug Development

No funding data available for Sophion Bioscience yet.

Get notified when Sophion Bioscience raises funding

Sophion Bioscience Alternatives & Competitors

Sophion Bioscience vs
Cytocentrics
Cytocentrics Germany

Biotechnology company using its ion channel expertise to support the pharmaceutical industry

Unknown
2 employees
Biotechnology, Health Care
Sophion Bioscience vs
Fluxion Biosciences
Fluxion Biosciences United States

A Cell Microsystems Company

Grant
10 employees
Biopharma, Biotechnology
Sophion Bioscience vs
Medherant Limited
Medherant Limited United Kingdom

Medherant develops drug delivery products for pain and CNS diseases using its proprietary TEPI Patch...

Unknown
17 employees

FAQ About Sophion Bioscience

Empowering drug discovery with superior, efficient automated patch clamping technology.
Sophion Bioscience was founded in 2000.
Sophion Bioscience operates in the following industries: Biotechnology.
Sophion Bioscience has approximately 51-200 employees.
Top alternatives and competitors to Sophion Bioscience include Cytocentrics, Fluxion Biosciences, Medherant Limited, CytoBioscience, Inc, Nanion Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sophion Bioscience and Cytocentrics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sophion Bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy